(BCHT) Birchtech Corp. Company Overview

What does Birchtech Corp. do?

Birchtech Corp. is an environmental-technology company listed on the NYSE American and Toronto Stock Exchange under BCHT. Its commercial core is specialty sorbent chemistry used to remove mercury from coal-fired power-plant emissions. It is now extending that expertise into water testing, media selection, carbon rejuvenation, equipment, consulting, and ion exchange.

Two businesses at very different stages

The clean-air operation is commercial. Birchtech supplies SEA® sorbents, performs emissions-management services, and earns intellectual-property licenses. It says the technology is used by more than 40% of the U.S. coal-fired sector and covers roughly 31 million tons of coal annually. The operating model is described on Birchtech’s official clean-air technology page.

Clean water is earlier-stage. It includes column testing, carbon reactivation, media and equipment supply, system design, and SEA-IX™ nuclear-grade resins. Diversification matters because current revenue remains tied to coal generation, while water could broaden customers and demand.

How does Birchtech make money?

Birchtech combines consumables with less predictable intellectual-property income. Utilities buy formulated sorbents for ongoing mercury control; counterparties pay to use patented processes. Demonstration, consulting, and equipment revenue is smaller but can precede recurring media purchases.

Which revenue stream matters most?

In FY2025, product revenue was $14.23 million, license revenue $3.16 million, and other revenue $0.23 million. Product sales represented 80.8% of revenue and licenses 17.9%. Product revenue repeats but carries input costs; licenses typically carry higher margins. Birchtech’s 2025 Form 10-K explicitly attributes the FY2025 gross-profit improvement partly to the higher level of licensing revenue.

Customer concentration changes the quality of revenue

Scale is limited. Three customers represented 29%, 11%, and 9% of FY2025 revenue; the top three were 65% combined in Q1 2026. Contract renewals, outages, generation levels, and purchasing decisions can therefore outweigh broad market growth.

What did Birchtech’s first quarter of 2026 show?

Q1 2026 showed stronger product demand, a lower net loss, and much more cash after an equity offering. Revenue increased 31.6% to $4.24 million. Product revenue rose 56.4% to $4.19 million, offsetting the absence of Q1 2025 license revenue.

Why did gross margin decline despite revenue growth?

Q1 2026 gross margin was 32.6%, versus 38.3% in Q1 2025. The decline primarily reflects mix: the prior-year quarter included $0.53 million of high-margin license revenue, while Q1 2026 was almost entirely product revenue. The company’s Q1 2026 earnings release emphasizes the same mix effect.

The offering changed solvency more than profitability

Birchtech sold 6.85 million shares for $16.44 million of gross proceeds. Cash reached $14.75 million and equity $11.17 million at March 31, 2026, but operations still used $2.21 million of cash. The Q1 2026 Form 10-Q therefore supports two simultaneous conclusions: near-term liquidity is much stronger, but self-funding operations have not yet been established.

Which turning points still shape Birchtech today?

Birchtech’s strategy reflects technology ownership, regulation-driven commercialization, litigation, and diversification. Each turning point changed today’s cash-flow profile or risk.

1. 2008–2011
   MES developed around mercury-control expertise, then became the operating subsidiary through the June 2011 merger. From that point, the public company focused on delivering mercury-capture technologies to power plants.
2. 2011–2015
   EPA’s Mercury and Air Toxics Standards created the compliance market. Utility demonstrations and long-term supply awards became the commercial engine.
3. 2017
   The company acquired the underlying SEA® patent rights from the Energy & Environmental Research Center Foundation, converting a licensed technology into owned intellectual property.
4. 2019–2024
   Birchtech pursued patent litigation. A federal jury returned a $57.1 million verdict in March 2024 against remaining CERT defendants, making enforcement economics central to the corporate story.
5. 2024
   The company launched its clean-water strategy, commissioned two Design Centers, changed its name from Midwest Energy Emissions to Birchtech, and graduated to the TSX under BCHT.
6. 2025
   The court entered a $78.40 million final judgment including prejudgment interest. At the same time, Birchtech spent $1.81 million on water-treatment R&D and reported a narrower annual loss.
7. 2026
   A 1-for-5 reverse split preceded the NYSE American listing. The $16.44 million gross equity raise strengthened liquidity and financed the next stage of water commercialization.

The $78.4 million judgment is an asset with timing risk

The final judgment is far larger than FY2025 revenue, but it is not collected cash. Defendants appealed in January 2026, and timing, legal costs, and the related profit-share obligation will affect net value. Operating plans therefore still require liquidity independent of collection.

Why is Birchtech’s clean-air franchise defensible but constrained?

The clean-air franchise benefits from patented chemistry, operating data, field expertise, and the cost of requalifying a regulated emissions process. Birchtech says SEA® has outperformed competing products at lower projected costs, and 16 purchasing generating units provide commercial validation.

Who are the main competitors?

The 2025 Form 10-K names Arq, Norit Activated Carbon, Calgon Carbon, and Nalco Water as major competitors. They generally have more capital, sales coverage, and manufacturing scale, so Birchtech must compete through measured performance and technical service.

The core constraint is the shrinking coal base

A strong niche in a contracting market can produce cash, but terminal growth is difficult. Mercury revenue depends on coal generation, gas prices, renewables, outages, weather, and regulation. The moat can defend share; it cannot stop plant retirements. That explains the move into water.

How could clean water change Birchtech’s growth profile?

The water strategy extends Birchtech from one contaminant and end market toward a broader treatment platform. Its clean-water platform covers PFAS, arsenic, selenium, mercury, chromium, iron, and other contaminants. The model is media-agnostic: test water, compare media, design systems, supply product, and potentially reactivate carbon for regional reuse.

Design Centers are the commercial funnel

Grand Forks performs small-scale column tests that simulate full-scale filters; State College focuses on carbon activation, reactivation, regeneration, and comparison. Birchtech’s official Design Center description states that the facilities support 24/7 sampling and four EPA-aligned PFAS methods. Testing reduces uncertainty and can lead to supply or system work.

What has to happen for the strategy to work?

Pilots must convert into paid projects and then repeat product or reactivation volume. Regional rejuvenation economics must justify a planned facility, which management warns may not be developed on acceptable terms. Demand must also persist if federal PFAS deadlines shift, making state rules, industrial wastewater, and other contaminants important.

How financially strong is Birchtech after the 2026 capital raise?

Birchtech is stronger than at year-end 2025 but not self-sustaining. FY2025 revenue rose 1.3% to $17.63 million and gross profit 4.2% to $7.40 million. Net loss improved from $10.80 million to $3.03 million as SG&A fell and a prior-year fair-value loss did not recur at the same magnitude.

Cash conversion remains the central financial test

FY2025 operating cash outflow improved to $0.70 million from $4.11 million; with $0.03 million of capex, simple free cash flow was about negative $0.73 million. Q1 2026 operating cash outflow worsened to $2.21 million as receivables and inventory rose while payables fell.

Capital allocation is shifting from survival to commercialization

The raise funded liquidity. Management can now finance working capital, water R&D, inventory, personnel, and a possible reactivation facility. FY2025 R&D was $1.81 million and Q1 2026 R&D $0.55 million. Water must eventually cover the larger cost base without repeated equity issuance.

Who owns Birchtech stock, and what does governance signal?

Birchtech has one common share class with one vote per share, so there is no dual-class control. Management and directors nevertheless have meaningful exposure. The 2026 proxy statement reports that officers and directors as a group beneficially owned 4.44 million shares, or 16.35%, based on the proxy’s ownership methodology.

What should investors infer from the board structure?

The 2026 proxy nominates four directors and proposes reducing authorized shares from 150 million to 50 million after the 1-for-5 reverse split. Dilution risk remains because 26.31 million shares were outstanding at the record date and the incentive plan retained capacity.

Management concluded that internal control over financial reporting was ineffective at December 31, 2025 after restating earlier periods for license-accounting changes. With licensing, litigation, related-party liabilities, and new listing duties, remediation affects confidence and management capacity.

What risks and opportunities could change Birchtech’s outlook?

Birchtech has asymmetric drivers. Water commercialization or judgment collection could be large relative to existing revenue, while customer loss, coal retirements, regulatory delay, or execution failure could be equally material.

The most material risks are company-specific

The opportunity set is broader than PFAS alone

Birchtech can address drinking water, industrial wastewater, nuclear resin, boiler-feed systems, and contaminants beyond PFAS. It reports a case study with 30% average cost improvement and more than $100,000 of savings, but scalable economics still require recurring revenue, margin, and customer expansion.

What matters most in a Birchtech valuation?

A single-stage DCF is poorly suited to Birchtech because clean air, clean water, and litigation have different risk and timing. Clean air can be modeled from volume, margins, licenses, SG&A, and working capital. Water requires scenarios for conversion, facility investment, margins, and execution. The judgment needs separate probability-weighted value.

Which KPIs should a DCF model prioritize?

Revenue growth alone is insufficient. Product and license revenue have different margins and recurrence. A model should track normalized gross margin, water operating costs, working capital, dilution, and terminal decline in coal volume.

• Clean-air volume: generating units served, customer concentration, product revenue, and plant utilization.
• Revenue quality: recurring product sales versus episodic license and legal proceeds.
• Water conversion: paid tests, project awards, media purchases, resin sales, and repeat customers.
• Margin structure: product gross margin, licensing mix, R&D, and incremental SG&A.
• Reinvestment: working capital, inventory, laboratory costs, and reactivation-plant capex.
• Financing: operating cash burn, remaining cash runway, and share issuance.

Do not capitalize every opportunity at full value. Water is early, litigation contested, and clean air exposed to coal. A credible model values each separately.

What is the key takeaway from Birchtech analysis?

Birchtech shows how specialized chemistry, patents, field data, and regulation can create a defensible niche. SEA® produced a commercial franchise and significant enforcement outcomes; management now seeks to reuse that capability in broader water markets.

The central tension is a strong current business serving a declining coal fleet while water is still being proven. The 2026 offering bought time but not profitability. Q1 product growth improved, yet cash burn, concentration, and ineffective controls remain material.